SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, and Cholestech Corporation have joined forces to offer an exclusive “Accu-Tame” program to dermatologists designed to ease the cumbersome process of prescribing isotretinoin for their patients, while helping them comply with iPLEDGETM pregnancy testing requirements as well as lipids and liver enzymes as recommended by the manufacturer.
